Luani Alvarado - 13 Feb 2026 Form 4 Insider Report for Kenvue Inc. (KVUE)

Role
Chief People Officer
Signature
/s/ Alla Berenshteyn, as attorney-in-fact
Issuer symbol
KVUE
Transactions as of
13 Feb 2026
Net transactions value
-$102,033
Form type
4
Filing time
18 Feb 2026, 20:35:24 UTC
Previous filing
10 Feb 2026
Next filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Alvarado Luani Chief People Officer 1 KENVUE WAY, SUMMIT /s/ Alla Berenshteyn, as attorney-in-fact 17 Feb 2026 0001967089

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KVUE Common Stock Options Exercise $0 +14,120 +30% $0.000000 60,722 13 Feb 2026 Direct
transaction KVUE Common Stock Tax liability $90,370 -4,843 -8% $18.66 55,879 13 Feb 2026 Direct F1
transaction KVUE Common Stock Options Exercise $0 +1,822 +3.3% $0.000000 57,701 13 Feb 2026 Direct
transaction KVUE Common Stock Tax liability $11,662 -625 -1.1% $18.66 57,076 13 Feb 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KVUE Restricted Stock Units Options Exercise $0 -14,120 -100% $0.000000 0 13 Feb 2026 Common Stock 14,120 Direct F2, F3
transaction KVUE Restricted Stock Units Options Exercise $0 -1,822 -100% $0.000000 0 13 Feb 2026 Common Stock 1,822 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for payment of taxes upon vesting of Restricted Stock Units ("RSUs").
F2 These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years.
F3 This award is fully vested.
F4 These RSUs were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value.